Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biopharmaceutical company with a market capitalization of $2.4 billion, recently sold shares of the company's common ...

Therapeutics, Inc. (NASDAQ:APGE), has sold 15,000 shares of the company's common stock, according to a recent SEC filing. The biotech company, currently valued at $2.37 billion, has received a ...

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.